Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

about

Keeping up with the prostate-specific membrane antigens (PSMAs): an introduction to a new class of positron emission tomography (PET) imaging agents

P2860

Q59130960-D16C3318-9ED2-4A81-847C-9A871640CCEC

P2860

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

Item

http://www.wikidata.org/entity/Q49827187

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@en

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@nl

type

Item

label

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@en

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@nl

altLabel

Combined model-based and patie ...... PyL, a PSMA-targeted PET agent

@en

prefLabel

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@en

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@nl

P1476

Combined model-based and patie ...... yL, a PSMA-targeted PET agent.

@en

P2093

Donika Plyku

http://www.w3.org/2001/XMLSchema#string

Esther Mena

http://www.w3.org/2001/XMLSchema#string

Martin A Lodge

http://www.w3.org/2001/XMLSchema#string

Martin G Pomper

http://www.w3.org/2001/XMLSchema#string

Steve Y Cho

http://www.w3.org/2001/XMLSchema#string

Steven P Rowe

http://www.w3.org/2001/XMLSchema#string

Zsolt Szabo

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges

Cancer statistics, 2016

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

124I PET-based 3D-RD dosimetry for a pediatric thyroid cancer patient: real-time treatment planning and methodologic comparison

New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.

Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography.

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy.

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

The thickness of the tear film.

P2888

s00259-018-3939-x

P304

989-998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-018-3939-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

George Sgouros

Robert F Hobbs

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29460025

http://www.w3.org/2001/XMLSchema#string

P921

18F

dosimetry

pet

P932

5918228

http://www.w3.org/2001/XMLSchema#string

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

about

P2860

P2860

Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932